+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Multicenter, randomized trial comparing oral, topic and oral plus topic mesalazine treatment in active Distal Ulcerative Colitis



Multicenter, randomized trial comparing oral, topic and oral plus topic mesalazine treatment in active Distal Ulcerative Colitis



Gastroenterology 118(4 Suppl 2 Part 1): AGA A778-AGA A779




(PDF emailed within 0-6 h: $19.90)

Accession: 035349986

Download citation: RISBibTeXText

DOI: 10.1016/S0016-5085(00)85256-7


Related references

Multicenter, randomized trial comparing oral, topic and oral plus topic mesalazine in prevention of relapse in Distal Ulcerative Colitis. Gastroenterology 120(5 Supplement 1): A 12, 2001

An economic evaluation comparing concomitant oral and topical mesalazine versus oral mesalazine alone in mild-to-moderately active ulcerative colitis based on results from randomised controlled trial. Journal of Crohn's and Colitis 3(3): 168-174, 2009

A randomized trial comparing 4.8 vs. 2.4 g/day of oral mesalazine for maintenance of remission in ulcerative colitis. Digestive and Liver Disease 47(11): 933-937, 2016

Is topical therapy necessary in acute distal colitis? Double-blind comparison of high-dose oral mesalazine versus steroid enemas in the treatment of active distal ulcerative colitis. Alimentary Pharmacology and Therapeutics 5(5): 513-522, 1991

Combined oral sodium butyrate and mesalazine treatment compared to oral mesalazine alone in ulcerative colitis: randomized, double-blind, placebo-controlled pilot study. Digestive Diseases and Sciences 45(5): 976-981, 2000

A controlled randomized trial comparing oral versus rectal mesalazine in the treatment of ulcerative proctitis. Gastroenterology 110(4 SUPPL ): A876, 1996

Controlled, open, randomized multicenter trial comparing the effects of treatment on quality of life, safety and efficacy of budesonide foam and betamethasone enemas in patients with active distal ulcerative colitis. Hepato-Gastroenterology 51(59): 1345-1349, 2004

Clinical trial: randomized-controlled clinical study comparing the efficacy and safety of a low-volume vs. a high-volume mesalazine foam in active distal ulcerative colitis. Alimentary Pharmacology and Therapeutics 26(9): 1237-1249, 2007

A double-blind dose-escalating trial comparing novel mesalazine pellets with mesalazine tablets in active ulcerative colitis. Alimentary Pharmacology & Therapeutics 21(2): 133-140, 2005

Oral beclomethasone dipropionate in pediatric active ulcerative colitis: a comparison trial with mesalazine. Journal of Pediatric Gastroenterology and Nutrition 50(4): 385-389, 2010

Clinical trial: controlled, open, randomized multicentre study comparing the effects of treatment on quality of life, safety and efficacy of budesonide or mesalazine enemas in active left-sided ulcerative colitis. Alimentary Pharmacology and Therapeutics 32(3): 368-376, 2011

Prognostic significance of endoscopic remission in patients with active ulcerative colitis treated with oral and topical mesalazine: a prospective, multicenter study. Inflammatory Bowel Diseases 18(6): 1006-1010, 2012

Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study. Gut 54(7): 960-965, 2005

Combined Oral and Enema Treatment With Pentasa (Mesalazine) Is Superior to Oral Therapy Alone in Patients With Extensive Mild/Moderate Active Ulcerative Colitis: A Randomised, Double Blind, Placebo Controlled Study. Yearbook of Gastroenterology 2006: 113-116, 2006

Clinical trial: Effects of an oral preparation of mesalazine at 4 g/day on moderately active ulcerative colitis. A phase III parallel-dosing study. Journal of Gastroenterology 46(1): 46-56, 2011